the pandemic influenza countermeasures portfolio · 2012-04-11 · help to develop and sustain...
TRANSCRIPT
![Page 1: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/1.jpg)
The Pandemic Influenza Countermeasures PortfolioCountermeasures Portfolio
Biomedical Advanced Research and Development Authority (BARDA)
Michael Perdue, Ph.D.Michael Perdue, Ph.D.Director, Influenza Division
HHS/ASPR/BARDA
![Page 2: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/2.jpg)
Today:
•Influenza: Virus((es) and disease) (s)
•Consequences of Pandemic InflI fluenza
•USUS response(s)response(s) andand evolutionevolution ofof thethe Pandemic Influenza Portfolio
•BARDA’s Influenza Division
( )
1
![Page 3: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/3.jpg)
InfluenzaVirus(es)
Mild URT infectionsMild URT infections
Severe URT Severe URT infectionsinfectionsVViiral pneumoniaral pneumonia
Bacterial pneumoniaBacterial pneumoniaSevereSevere AAcutecuteSevereSevere AcuteAcute RespiratoryRespiratory ddiseaseiseaseRespiratoryRespiratory diseasedisease..
Systemic infectionsSystemic infections
EpidemicsEpidemics ppandemicsandemicsEpidemicsEpidemics, , pandemicspandemics, , sporadic infectionssporadic infections
High risk groupsHigh risk groups
Disease(s)Disease(s)
2
![Page 4: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/4.jpg)
1918-19 Influenza
3
![Page 5: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/5.jpg)
Measures of Disease BurdenEstimates of morbidity and mortality 2009 pH1N1 Influenza
A il 2009 A il 2010April 2009 - April 2010
Dead12 469 on
Hospitali ed
12,469
0 po
pula
tio
C
Hospitalized274,304
er 1
00,0
00
Cases60,837,748
4 4 9 4 5
Rat
e pe
0-4
5-24
25-4
9
50-6
4
≥65
Slide courtesy of Lyn Slide courtesy of Lyn FinelliFinelli-- CDCCDC
![Page 6: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/6.jpg)
H1N1 hospitalization rates
5
![Page 7: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/7.jpg)
OUR MISSION: Using the influenza virus aggainst itself
AAdvancing science dvancing science and and technology into technology into
countermeasurescountermeasures
6
![Page 8: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/8.jpg)
Slide courtesy of Slide courtesy of D N C CDCD N C CDCDr. N. Cox CDCDr. N. Cox CDC
![Page 9: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/9.jpg)
New Technologies New Technologies advantage? advantage?
8
![Page 10: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/10.jpg)
HHS Responses to Influenza Pandemics
Effective Vaccines and Programs-More, Better, Faster
Effective Antivirals and Delivery- Avoiding resistanceEffective Antivirals and Delivery- Avoiding resistance
Sensitive Specific Diagnostics Usage and interpretationSensitive, Specific Diagnostics- Usage and interpretation
Mitigation of Severe Respiratory Impact- Stockpiles, surge, simplicity
9
![Page 11: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/11.jpg)
Infrastructure Development-cell based pproduction
10
![Page 12: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/12.jpg)
![Page 13: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/13.jpg)
ID International Program Objectives
1. Protect America by reducing risks of influenza epidemics outside our borders-one worldepidemics outside our onehealth.
borders one world one
2.manuffacturiing capabilibilitiies andd capaci dHelp to develop and sustain influenza vaccine
ity and pandemic readiness: promote investment; establish partnerships
3.p pHelp achieve sustainable influenza vaccine
BARDA’s niq e rproduction capacity
eso rcesworldwide by leveraging
BARDA’s unique resources.
1212
![Page 14: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/14.jpg)
International Capacity BuildingTotal Financial Commitment through 2009: $52 million
• FY 2005 $1 million ASPR funding to Vabiotech-Vietnam•• FYFY 20062006 $10$10 milliillion off emergency suppllementtall
funding to WHO; granted to India, Indonesia, Vietnam, Thailand, Mexico & Brazil
• FY 2007 Funding requested in annual budget; notFY 2007 Funding appropriated
requested in annual budget; not
• FY 2008 $14.4 million of annual funding to WHO; granted to six original grantees plus Egypt, Serbia and Romania.
• FY 2009 $3.6 million to WHO; granted to Russia’s Institute for Experimental Medicine; plus $7.9 million to PATH; and $3.5 for rapid diagnostics to support clinical trials$3 5 for rapid diagnostics to support clinical trials
• FY 2010 $11M to WHO, Universities: Lausanne, NC State, Utah State. Non-profit: IDRI (Seattle)
• FY 2011 $11: WHO, adjuvants, training multiproductFY 2011 $11: WHO adjuvants training, multiproduct manufacturing feasibility
13
![Page 15: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/15.jpg)
Serum Institute of India, Pune
14
![Page 16: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/16.jpg)
BARDA Influenza Division(Transitional)(Transitional)
Director: Michael Perdue (until July 19)epuD t Di t R b t H bD ty Director: Robert Huebner
Current Staff: 32 (27 FTE 5 Contractors)Current Staff: 32 (27 FTE, 5 Contractors)
5 Divisional Teams: Antivirals; Vaccines-advanced development; Vaccines Stockpiles; Diagnostics/Devices; “International”Vaccines-Stockpiles; Diagnostics/Devices; “International”
BARDA Pandemic Influenza PBARDA P d i I fl Program: > 50 t ff i l di> 50 staff including manufacturing, clinical, regulatory, innovation
15
![Page 17: The Pandemic Influenza Countermeasures Portfolio · 2012-04-11 · Help to develop and sustain influenza vaccine ity and pandemic readiness: promote investment; establish partnerships](https://reader031.vdocuments.us/reader031/viewer/2022041019/5ece7e9c854f81795922cdd6/html5/thumbnails/17.jpg)
Interfacing with Interfacing with BARDABARDA
•• wwwwww.phe.gov.phe.govProgramProgram descriptiondescription informationinformation── ProgramProgram descriptiondescription, , informationinformation, , newsnews announcementsannouncementsnewsnews, , announcementsannouncements
•• wwwwww.medicalcountermeasures.gov.medicalcountermeasures.gov── PPoortrtaao ao al tl toooo BARD BARDAA── RegisterRegister, request , request a meetinga meeting── TTeech Wch Waatchtch
•• wwwwww.fedbizopps.gov.fedbizopps.gov── OfOfficial ficial announcements and detailed announcements and detailed information about all information about all
governmentgovernment contractcontract solicitationssolicitationsgovernmentgovernment contractcontract solicitationssolicitations
1616161616